Hinweis-Modus ist eingeschaltet Ausschalten

516060 - ICBCCS CSI Brand Name Drug Industry ETF (CNY) (CNE100004FV2)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
CNE100004FV2
516060 ISIN
Exchange Traded Funds (ETF)
Fondstyp
ICBC Credit Suisse
Anbieter
-
NAV pro Aktie
09/02/2021
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOXXX
CFI
516060
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
China
Geographie
CSI Innovative Drug Industry Index
Benchmark
0.52 %
Gesamtkostenquote
Physical
Replikationsmethode
Nein
UCITS
Passive (Index)
Management Style

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (516060)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The ICBCCS CSI Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI Innovative Drug Industry Index by investing in a portfolio comprised primarily of Chinese companies

516060 profile

The ICBCCS CSI Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The ICBC Credit Suisse fund’s base currency is CNY and the share class was registered 09.02.2021 with unique ISIN - CNE100004FV2. Main exchange is Shanghai SE and ticker symbol is 516060. The total expense ratio is 0.52%. The ICBCCS CSI Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.